At the ESMO congress, the German biotech reported ... "This new dataset further supports the encouraging results we have seen for BNT211 to date," commented Prof Özlem Türeci, BioNTech's chief ...
At ESMO, the mRNA specialist reported updated ... as well as infiltrate and survive in the hostile microenvironment of the tumour. “BNT211 aims to address two of the key limitations of CAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback